NCT05107921View on ClinicalTrials.gov

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 20, 2024

Study Completion Date

October 20, 2024

Conditions
Familial Exudative Vitreoretinopathies
Interventions
DRUG

Bromfenac Sodium

The study participants will receive bromfenac sodium hydrate eyedrops twice daily for 14 days.

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER